Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Visual Acuity and Age of Symptom Onset in a Large Chinese Cohort of Patients with Stargardt Disease

View through CrossRef
Stargardt disease is the most common form of juvenile-onset inherited macular dystrophy, with high phenotypic heterogeneity. There are limited data documenting the characteristics of Best Corrected Visual Acuity (BCVA) and age of symptom onset of patients with Stargardt disease in Chinese population. In this study, 169 patients with clinical and genetic diagnosis of Stargardt disease were recruited. BCVA, age, age of symptom onset, disease duration time and genetic information were collected and analyzed. We found that the average BCVA was 1.16±0.61 logMAR, 63.6% of patients with severe visual impairment (≤1 logMAR); the mean age of symptom onset was 13.63±12.72 years (yrs) old, 61.36% of patients had an onset earlier than 12; BCVA level was associated with genotype and disease duration, but had no direct correlation with neither age of symptom onset nor age; severe genotype (≥2 severe variants, severe variants were defined as those predicted to introduce a premature truncating codon in the protein or to affect splicing) was also associated with earlier age of symptom onset. Our data will serve as a well-founded reference for genetic counseling and better management of these patients.
Title: Visual Acuity and Age of Symptom Onset in a Large Chinese Cohort of Patients with Stargardt Disease
Description:
Stargardt disease is the most common form of juvenile-onset inherited macular dystrophy, with high phenotypic heterogeneity.
There are limited data documenting the characteristics of Best Corrected Visual Acuity (BCVA) and age of symptom onset of patients with Stargardt disease in Chinese population.
In this study, 169 patients with clinical and genetic diagnosis of Stargardt disease were recruited.
BCVA, age, age of symptom onset, disease duration time and genetic information were collected and analyzed.
We found that the average BCVA was 1.
16±0.
61 logMAR, 63.
6% of patients with severe visual impairment (≤1 logMAR); the mean age of symptom onset was 13.
63±12.
72 years (yrs) old, 61.
36% of patients had an onset earlier than 12; BCVA level was associated with genotype and disease duration, but had no direct correlation with neither age of symptom onset nor age; severe genotype (≥2 severe variants, severe variants were defined as those predicted to introduce a premature truncating codon in the protein or to affect splicing) was also associated with earlier age of symptom onset.
Our data will serve as a well-founded reference for genetic counseling and better management of these patients.

Related Results

Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct Introduction Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Clinical results according to cause of endophthalmitis
Clinical results according to cause of endophthalmitis
Abstract Purpose To analysis clinical features according to the cause of endophthalmitis and evaluate the factors associa...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Treatment of age-related visual impairment with a mitochondrial therapeutic
Treatment of age-related visual impairment with a mitochondrial therapeutic
ABSTRACT Age-related visual decline and disease due to neural dysfunction are major sources of disability that have resisted effective treatment. In light of eviden...
Multiple myeloma patients undergoing chemotherapy: Which symptom clusters impact quality of life?
Multiple myeloma patients undergoing chemotherapy: Which symptom clusters impact quality of life?
AbstractAims and ObjectivesTo identify symptom clusters and examine their association with health‐related quality of life.BackgroundMultiple myeloma patients undergoing chemotherap...

Back to Top